Skip to main content
Topas Therapeutics GmbH

Falkenried 88, Haus A
20251 Hamburg GERMANY

+49 40 302089010
info@topas-therapeutics.com

Press Releases

Archive

Stay updated with the latest news and developments from Topas Therapeutics, including corporate announcements, clinical trial progress, and scientific advancements in immunotherapy research. For detailed information, please explore our press releases:

Events

BIO 2025: BIO International Convention

Boston, MA

16-19 June 2025

Topas In The News

Discover the latest news, articles, and whitepapers featuring Topas Therapeutics’ work and innovations in immune tolerance and autoimmune disease treatment development.

Endpoints News – 5 May 2025

Exclusive: Topas claims success in early test of ‘immune tolerance’ therapy for celiac disease.

“There is both very much a medical need and big commercial opportunity in celiac,” Topas CEO Hugo Fry told Endpoints.

Read more
GoingPublic – 22 November 2024

“We still believe we’re an undiscovered gem” Charting the Future of Immune Tolerance: Insights from the CEO of TOPAS

Interview between Hugo Fry, Chief Executive Officer at Topas Therapeutics and Urs Moesenfechtel, Editorial Director of GoingPublic 

Read more
Drug Target Review – 16 October 2024

Women in STEM with Cristina de Min

By: Cristina de Min, MD, Chief Medical Officer at Topas Therapeutics

Read more
European Pharmaceutical Review – 28 June 2024

The Promise and Hurdles of Restoring Immune Tolerance

By: Dr Christian Schröter, Chief Operating Officer at Topas Therapeutics

Read more

Connect with our team and learn how we are transforming the treatment of autoimmune diseases

Contact Us